🇺🇸 CYTK — Cytokinetics, Incorporated

Salud Compra fuerte
← Volver

Precio actual

62,31 USD

Máx. histórico

108,06

1030 días

Split 1:6 del 25/06/2013

Caída desde máximo

-42,34%

Rango 52 semanas

58,05 – 88,31

Variación hoy

+0,45%

Cierre anterior

62,03

Rango de hoy

62,05 – 64,37

Volumen hoy

1.699.286

Peor caída histórica

-97,06%

05/05/2004 → 10/10/2014

Recuperado en 3377 días

Volatilidad anualizada ⓘ

69,37%

Información
Nombre completo
Cytokinetics, Incorporated
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
673
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
107,39 USD (puede no estar actualizado)
Primera cotización
30/04/2004
Precio actualizado
hace 5 horas
Sobre la empresa

Cytokinetics, Incorporated, a biopharmaceutical company, focuses on discovering, developing, and commercializing novel muscle activators and muscle inhibitors as potential treatments for debilitating diseases in the United States. The company markets MYQORZO, a novel, oral, and small molecule cardiac myosin inhibitor for the treatment of symptomatic oHCM. It also develops Aficamten, a novel, oral, and small molecule cardiac myosin inhibitor for the treatment of HCM; and omecamtiv mecarbil, a potential treatment across the continuum of care in heart failure with severely reduced ejection fraction. In addition, the company is involved in developing and Ulacamten, a novel, selective, oral, and small molecule cardiac myosin inhibitor designed to reduce the hypercontractility associated with heart failure with preserved ejection fraction in Phase 1 clinical trials; and CK-089, a fast skeletal muscle troponin activator in Phase 1 clinical trials. Cytokinetics, Incorporated was incorporated in 1997 and is headquartered in South San Francisco, California.

Splits Registrados en el histórico de precios
Fecha Ratio
25/06/2013 1:6
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
04/03/2025 42,50 44,58 41,92 43,69 +1,87% 6,26% 1.787.900
03/03/2025 46,00 46,58 42,61 42,89 -6,76% 8,63% 1.864.500
28/02/2025 44,36 46,95 42,87 46,00 -3,06% 9,20% 2.017.100
27/02/2025 47,04 48,54 46,91 47,45 +1,26% 3,47% 1.201.600
26/02/2025 47,14 47,80 46,17 46,86 +0,45% 3,46% 984.400
25/02/2025 48,67 48,67 46,06 46,65 -3,10% 5,36% 1.858.900
24/02/2025 50,27 50,98 48,10 48,14 -4,22% 5,73% 1.420.300
21/02/2025 51,57 51,74 48,88 50,26 -1,68% 5,55% 2.169.400
20/02/2025 46,61 51,39 46,00 51,12 +10,17% 11,56% 2.790.800
19/02/2025 45,20 46,74 45,05 46,40 +2,23% 3,74% 1.749.400
18/02/2025 45,60 48,30 45,38 45,39 -1,67% 6,40% 1.779.200
14/02/2025 41,54 46,26 40,77 46,16 +10,91% 13,22% 4.821.300
13/02/2025 43,00 43,16 41,58 41,62 -1,33% 3,67% 1.556.600
12/02/2025 40,65 42,33 40,53 42,18 +1,49% 4,43% 1.785.900
11/02/2025 42,05 43,05 41,47 41,56 -1,54% 3,76% 1.186.200
10/02/2025 42,90 43,86 41,71 42,21 -1,29% 5,01% 2.616.100
07/02/2025 46,23 46,23 42,72 42,76 -7,39% 7,59% 3.642.900
06/02/2025 50,39 50,82 45,70 46,17 -8,41% 10,16% 3.901.200
05/02/2025 49,82 51,63 49,57 50,41 +2,46% 4,13% 897.200
04/02/2025 48,06 49,26 47,71 49,20 +1,51% 3,23% 1.319.000
03/02/2025 48,47 49,72 48,15 48,47 -2,00% 3,24% 680.400
31/01/2025 49,68 50,49 48,27 49,46 -1,02% 4,47% 1.099.100
30/01/2025 48,93 50,53 48,48 49,97 +2,71% 4,19% 1.139.400
29/01/2025 48,61 49,78 48,07 48,65 -0,10% 3,52% 766.300
28/01/2025 50,00 50,00 48,68 48,70 -2,48% 2,64% 862.800
27/01/2025 51,02 52,80 49,21 49,94 -1,60% 7,04% 1.338.500
24/01/2025 47,75 51,16 47,60 50,75 +6,04% 7,46% 2.100.000
23/01/2025 46,33 47,90 44,92 47,86 +2,22% 6,43% 1.639.200
22/01/2025 46,52 47,62 46,26 46,82 +2,18% 2,92% 1.358.400
21/01/2025 45,92 46,32 45,26 45,82 +0,17% 2,31% 1.255.100